Genentech Seeks FDA OK for Tecentriq With Avastin in Common Form of Liver Cancer

Date : 01/27/2020 @ 1:01PM
Source : Dow Jones News
Stock : Roche Holdings Ltd AG (QX) (RHHBY)
Quote : 42.54  -1.49 (-3.38%) @ 10:20PM
After Hours
Last Trade
Last $ 42.60 ▲ 0.06 (0.14%)

Genentech Seeks FDA OK for Tecentriq With Avastin in Common Form of Liver Cancer

Historical Stock Chart

1 Month : From Jan 2020 to Feb 2020

Click Here for more Roche (QX) Charts.

By Colin Kellaher


Roche Holdings AG's (ROG.EB) Genentech unit on Monday said it filed a supplemental biologics license application with the U.S. Food and Drug Administration for Tecentriq in combination with Avastin in the most common form of liver cancer.

Genentech said the filing covers the treatment of people with unresectable hepatocellular carcinoma who haven't received prior systemic therapy.

The FDA is reviewed the filing under its Real-Time Oncology Review pilot program, which aims to explore a more efficient review process to ensure safe and effective treatments are available to patients as early as possible.

Genentech is conducting an extensive development program for Tecentriq, including ongoing and planned Phase 3 studies across bladder, genitourinary, skin, breast, gastrointestinal, gynecological and head and neck cancers.


Write to Colin Kellaher at


(END) Dow Jones Newswires

January 27, 2020 07:46 ET (12:46 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.